跳至主要内容
临床试验/IRCT20180203038600N1
IRCT20180203038600N1已完成2 期

A randomized clinical trial for comparison of two methods of BOTOX injection (FTP & FSFD) to improve headache frequency & quality of life of migrainous headache patients

Rafsanjan University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients who have at least 15 days headache that maintain for 4 hour or more
  • Patients who had no improvement in severity & frequency of headaches by using prophylactic drug agents like that Beta blockers, CCB, anti convulsive drugs & anti depressant

排除标准

  • History of BOTOX injection or other Botulinum serotypes
  • Neuromuscular junction disease
  • Psychologic disorders that have negative impact on clinical trial
  • Beck severity scale of depression more than 24
  • Primary or secondary headaches due to another reasons
  • Complicated migraine
  • Drug sensivity
  • Coagulopathy
  • Infection of injection skin site

研究者

相似试验

Comparison of two methods of BOTOX injection (FTP &... | 临床试验